Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2012

Open Access 01-12-2012 | Research article

Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis

Authors: Fakhrul M Islam, Jianyun Wu, James Jansson, David P Wilson

Published in: BMC Public Health | Issue 1/2012

Login to get access

Abstract

Background

Antiretroviral therapy (ART) has substantially decreased mortality and HIV-related morbidity. However, other morbidities appear to be more common among PLHIV than in the general population. This study aimed to estimate the relative risk of renal disease among people living with HIV (PLHIV) compared to the HIV-uninfected population.

Methods

We conducted a systematic review and meta-analysis of relative risks of renal disease among populations of PLHIV reported in studies from the peer-reviewed literature. We searched Medline for relevant journal articles published before September 2010, yielding papers published during or after 2002. We also searched conference proceedings of the International AIDS Society (IAS) and Conference on Retroviruses and Opportunistic Infections (CROI) prior to and including 2010. Eligible studies were observational studies reporting renal disease defined as acute or chronic reduced renal function with glomerular filtration rate less than or equal to 60 ml/min/1.73 m2 among HIV-positive adults. Pooled relative risks were calculated for various groupings, including class of ART drugs administered.

Results

The overall relative risk of renal disease was 3.87 (95% CI: 2.85-6.85) among HIV-infected people compared to HIV-uninfected people. The relative risk of renal disease among people with late-stage HIV infection (AIDS) was 3.32 (1.86-5.93) compared to other PLHIV. The relative risk of renal disease among PLHIV who were receiving antiretroviral therapy (ART) was 0.54 (0.29-0.99) compared to treatment-naïve PLHIV; the relative risk of renal disease among PLHIV who were treated with tenofovir was 1.56 (0.83-2.93) compared to PLHIV who were treated with non-tenofovir therapy. The risk of renal disease was also found to significantly increase with age.

Conclusion

PLHIV are at increased risk of renal disease, with greater risk at later stages of infection and at older ages. ART prolongs survival and decreases the risk of renal disease. However, less reduction in renal disease risk occurs for Tenofovir-containing ART than for other regimens.
Appendix
Available only for authorised users
Literature
1.
Meguid El Nahas A, Bello AK: Chronic kidney disease: the global challenge. Lancet. 2005, 365 (9456): 331-40.CrossRefPubMed
2.
Ibrahim F, et al: Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure. AIDS. 2010, 24 (14): 2239-2244. 10.1097/QAD.0b013e32833c85d6.CrossRefPubMed
3.
Horberg M, et al: Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010, 53 (1): 62-69. 10.1097/QAI.0b013e3181be6be2.CrossRefPubMed
4.
Crane HM, et al: Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir. AIDS. 2007, 21 (11): 1431-1439. 10.1097/QAD.0b013e3281fc9320.CrossRefPubMed
5.
Bailie GR, Uhlig K, Levey AS: Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease. Pharmacotherapy. 2005, 25 (4): 491-502. 10.1592/phco.25.4.491.61034.CrossRefPubMed
6.
Hogg RJ, et al: National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003, 111 (6 Pt 1): 1416-1421.CrossRefPubMed
7.
Deti E, et al: Chronic Renal Failure in HIV-Infected Patients: Incidence and Risk Factors (ANRS CO3 Aquitaine Cohort, France). 17th Conference on Retroviruses and Opportunistics Infections. 2010, San Francisco, CA.
8.
Atta MG, et al: Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant. 2006, 21 (10): 2809-2813. 10.1093/ndt/gfl337.CrossRefPubMed
9.
Buskin SE, et al: Trends in nephropathy among HIV-infected patients. J Natl Med Assoc. 2009, 101 (12): 1205-1213.CrossRefPubMed
10.
Campbell LJ, et al: Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009, 10 (6): 329-336. 10.1111/j.1468-1293.2008.00691.x.CrossRefPubMed
11.
Crum-Cianflone N, et al: Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS. 2010, 24 (6): 353-360. 10.1089/apc.2009.0326.CrossRefPubMedPubMedCentral
12.
Franceschini N, et al: Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients. J Acquir Immune Defic Syndr. 2006, 42 (3): 368-372. 10.1097/01.qai.0000220165.79736.d3.CrossRefPubMed
13.
14.
Ganesan A, et al: Determinants of Incident Chronic Kidney Disease in a Cohort of HIV-infected Patients with Free Access to Care. 17th Conference on Retroviruses and Opportunistics Infections. 2010, San Francisco
15.
Heffelfinger J, et al: Renal Impairment Associated with the Use of Tenofovir. 13th Conference on Retroviruses and Opportunistic Infections. 2006, Denver, CO
16.
Jacobson LP, et al: Proteinuria among HIV-Infected HAART recipients in the multicenter AIDS cohort study (MACS). 4th Conference on HIV Pathogenesis and Treatment and Prevention. 2007, Sydney
17.
Jones R, et al: Renal Dysfunction with Tenofovir DF Containing HAART Regimens is not Observed more Frequently: a Cohort and Case Control Study in The XV International AIDS Conference. 2004, Bangkok
18.
Krawczyk CS, et al: Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS. 2004, 18 (16): 2171-2178. 10.1097/00002030-200411050-00009.CrossRefPubMed
19.
20.
Lucas GM, et al: End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007, 21 (18): 2435-2443. 10.1097/QAD.0b013e32827038ad.CrossRefPubMed
21.
Mocroft A, et al: Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010, 24 (11): 1667-1678. 10.1097/QAD.0b013e328339fe53.CrossRefPubMed
22.
Reisler R, et al: Chronic Kidney Disease and the Use of HAART. 12th Conference on Retroviruses and Opportunistics Infections. 2005, Boston, Massachusetts, USA
23.
Roe J, et al: HIV care and the incidence of acute renal failure. Clin Infect Dis. 2008, 47 (2): 242-249. 10.1086/589296.CrossRefPubMed
24.
Szczech LA, et al: Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002, 61 (1): 195-202. 10.1046/j.1523-1755.2002.00094.x.CrossRefPubMed
25.
Vanig T, et al: Tenofovir (TDF) Effect on Renal Function Factoring in both MDRD-Calculated Glomerular Filtration rate (GFR) and Spot Urine Protein-to-Creatinine (UPC) Ratio in AIDS 2008 - XVII International AIDS Conference. 2008, Mexico
26.
Wei A, et al: Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int. 2003, 64 (4): 1462-1471. 10.1046/j.1523-1755.2003.00230.x.CrossRefPubMed
27.
Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998, 52 (6): 377-384. 10.1136/jech.52.6.377.CrossRefPubMedPubMedCentral
28.
D'Agostino RB, et al: Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990, 9 (12): 1501-1515. 10.1002/sim.4780091214.CrossRefPubMed
29.
Lollgen H, Bockenhoff A, Knapp G: Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med. 2009, 30 (3): 213-224. 10.1055/s-0028-1128150.CrossRefPubMed
30.
Bohning D, et al: Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator. Biostatistics. 2002, 3 (4): 445-457. 10.1093/biostatistics/3.4.445.CrossRefPubMed
31.
32.
33.
Liberati A, et al: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009, 62 (10): e1-34. 10.1016/j.jclinepi.2009.06.006.CrossRefPubMed
34.
Moher D, et al: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6 (7): e1000097-10.1371/journal.pmed.1000097.CrossRefPubMedPubMedCentral
35.
Palella F, et al: Proteinuria, Glomerular Filtration Rate Reductions, and Associated Factors among HIV-infected and -uninfected Men in the Multicenter AIDS Cohort Study. 15th Conference on HIV Pathogenesis and Treatment and Prevention, Paper#973. 2008, Boston, MA, USA
36.
Cooper RD, et al: Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis. 2010, 51 (5): 496-505. 10.1086/655681.CrossRefPubMed
37.
38.
Wyatt CM, et al: The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS. 2008, 22 (14): 1799-1807. 10.1097/QAD.0b013e32830e0152.CrossRefPubMedPubMedCentral
Metadata
Title
Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis
Authors
Fakhrul M Islam
Jianyun Wu
James Jansson
David P Wilson
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2012
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-12-234

Other articles of this Issue 1/2012

BMC Public Health 1/2012 Go to the issue

Study protocol

Supporting teachers and children in schools: the effectiveness and cost-effectiveness of the incredible years teacher classroom management programme in primary school children: a cluster randomised controlled trial, with parallel economic and process evaluations

Research article

Development and validation of sunlight exposure measurement questionnaire (SEM-Q) for use in adult population residing in Pakistan

Research article

Survived but feeling vulnerable and insecure: a qualitative study of the mental preparation for RTW after breast cancer treatment

Research article

UK ethnicity data collection for healthcare statistics: the South Asian perspective

Research article

NHS health checks through general practice: randomised trial of population cardiovascular risk reduction

Research article

Alcohol, psychoactive substances and non-fatal road traffic accidents - a case-control study